The neural-derived exosomes, isolated from plasma of AD patients, showed significantly higher levels of Aβ1-42, total tau, p-T181 tau and p-S396 tau, as compared to the controls, which provided a high predictability of disease development in the preclinical stage [142]. The gene discussed is MAPT; the disease is Alzheimer disease.